Allspring Global Investments Holdings, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 1,786 shares of CRNX stock, worth $94,925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,786Holding current value
$94,925% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
241Shares Held
79.5MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$334 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$331 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$313 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$263 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$237 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.86B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...